Bolt Biotherapeutics
BOLT
BOLT
61 hedge funds and large institutions have $54.8M invested in Bolt Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
35% less capital invested
Capital invested by funds: $84.8M → $54.8M (-$30M)
Holders
61
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$918K | |
| 3 | +$562K | |
| 4 |
Renaissance Technologies
New York
|
+$507K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$408K |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$3.19M | |
| 3 | -$2.37M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.36M |
| 5 |
AC
Armistice Capital
New York
|
-$1.1M |